[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-353384-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-353384-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-cervicovaginal-microbiome-an-emerging-determinant-of-hpv-infection-and-disease","The cervicovaginal microbiome: an emerging determinant of HPV infection and disease","","Human papillomaviruses (HPVs) are epitheliotropic viruses that drive diseases from cutaneous warts to invasive cancers, with high-risk HPV types responsible for nearly one-third of virus-associated cancers globally, including essentially all cervical cancers. Clinical and epidemiological work increasingly links the host cervicovaginal microbiome (CVM) to HPV infection, persistence, and disease development, while mechanisms remain difficult to define. This review synthesizes current understanding of how bacterial CVM components may influence HPV pathogenesis and neoplastic progression, and highlights challenges such as causality, timing, and directionality, alongside emerging in vitro and in vivo models to study trans-kingdom interactions.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-cervicovaginal-microbiome-an-emerging-determinant-of-hpv-infection-and-disease/353384/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-cervicovaginal-microbiome-an-emerging-determinant-of-hpv-infection-and-disease/353384.png","ImageObject",300,407,{"name":42,"@type":43},"mieayamfan","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What role does the cervicovaginal microbiome play in HPV infection and disease?","Question",{"text":63,"@type":64},"The review describes the CVM as a key determinant influencing HPV infection, persistence, and disease development, supported by clinical and epidemiological evidence.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why has it been hard to prove causality between microbiota and HPV pathogenesis?",{"text":68,"@type":64},"Mechanistic evidence needed for causality is limited by challenges in studying HPV and the microbiome, including difficulties addressing temporal dynamics and directionality of the relationship.",{"name":70,"@type":61,"acceptedAnswer":71},"What kinds of models can help clarify HPV–microbiome interactions?",{"text":72,"@type":64},"Emerging in vitro and in vivo models are presented as powerful tools to recapitulate cervicovaginal microbiome dynamics and the complexity of the HPV life cycle.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},353384,1790175061,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},962090893677,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","| Editor’s Pick | Host-Microbial Interactions | Minireview  \nThe cervicovaginal microbiome: an emerging determinant of HPV infection and disease  \nMegan E. Spurgeon1,2,3  \nAUTHOR AFFILIATIONS See affiliation list on p. 14.  \nABSTRACT Human papillomaviruses (HPVs) are epitheliotropic viruses that cause diseases ranging from cutaneous warts to invasive cancers. HPVs exhibit tropism for the epithelial lining of the skin, oral cavity, and anogenital tract. A subset of HPVs, known as high-risk HPVs, have oncogenic potential and cause nearly one-third of all virus-associated cancers worldwide, including essentially all cervical cancers, most other anogenital cancers, and a growing percentage of head and neck cancers. A large and growing body of clinical and epidemiological research has established the host microbiome, or the collection of microorganisms on and within the body, as a key determinant of HPV infection, persistence, and disease development. In this review, an overview of the current understanding of associations between bacterial components of the host cervicovaginal microbiome (CVM) and aspects of HPV pathogenesisis discussed. Potential mechanisms through which the CVM influences HPV infection and neoplastic disease development are also presented. The inherent challenges of studying HPVs and the microbiome have impeded progress to define not only the underlying mechanisms involved in HPV-CVM interactions, but also the ability to address remaining questions such as causality, temporal dynamics, and the directionality of this relationship. Emerging in vitro and in vivo models provide powerful opportunities to address these outstanding questions and increase our understanding of trans-kingdom interactions that contribute to HPV infection and subsequent disease.  \nKEYWORDS human papillomavirus, microbiome, viral pathogenesis, cervical cancer, murine papillomavirus  \nV iruses are obligate intracellular parasites that depend on their hosts to replicate.  \nA productive outcome of viral infection is therefore heavily dependent upon the host conditions that viral particles, genomes, and gene products encounter at steps throughout the viral life cycle. Factors that can influence the successful replication of viruses include the natural flora present in target tissues and cells, metabolic activity that sustains cell growth, functional transcriptional and translational machinery, and the activity of signaling pathways. Together, these conditions create an environment that is either conducive or detrimental to viral replication and progeny virion production. The study of these host conditions and their collective impact on viruses will not only better our understanding of viral pathogenesis but may also help reveal new therapeutic vulnerabilities.  \nAn important host factor increasingly recognized for its effects on human health is the microbiome, a term that describes the ecological niche of microorganisms present within and on the body. The microbiome is composed of both commensal and/or pathogenic microbiota, including bacteria, yeast, fungi, and viruses. It often adopts unique and dynamic compositions across anatomical sites and pathological conditions (1) . Collectively, microbiota are estimated to comprise at least half of all cells in the human body, with the remaining cells being of human origin (2, 3) . These microbial  \nEditor Herman W. Favoreel, Universiteit Gent, Merelbeke, Belgium  \nAddress correspondence to Megan E. Spurgeon,  \ncommunities exert such a significant influence on tissue homeostasis and function that the microbiome has been referred to as the “second genome” of the human body, affecting various aspects of human health and the etiology of disease (4, 5). Considering its pervasive impact on human physiology, the microbial milieu encountered during viral infection likely plays a significant role in shaping viral pathogenesis, transmission, and disease.  \nA growing body of evidence suggests that the microbiome","cbCaiq2pnf6FzvBD","https://ap.wps.com/l/cbCaiq2pnf6FzvBD","pdf",2544933,22,"English","# Abstract\n# Background\n## Papillomaviruses: tropism and life cycle","[{\"question\":\"What role does the cervicovaginal microbiome play in HPV infection and disease?\",\"answer\":\"The review describes the CVM as a key determinant influencing HPV infection, persistence, and disease development, supported by clinical and epidemiological evidence.\"},{\"question\":\"Why has it been hard to prove causality between microbiota and HPV pathogenesis?\",\"answer\":\"Mechanistic evidence needed for causality is limited by challenges in studying HPV and the microbiome, including difficulties addressing temporal dynamics and directionality of the relationship.\"},{\"question\":\"What kinds of models can help clarify HPV–microbiome interactions?\",\"answer\":\"Emerging in vitro and in vivo models are presented as powerful tools to recapitulate cervicovaginal microbiome dynamics and the complexity of the HPV life cycle.\"}]","The cervicovaginal microbiome: an emerging determinant of HPV infection and disease | PDF",1790105036,55,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2ab5d074479b9fa4738c4e287cbbd076.webp",983,1315,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1edb8a2536cc489fa481c827abeacf83.webp",982,1314,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2805679695ddb8e9a715a12da764055c.webp",981,1312,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cd5182b27e047d2c220a6ce42e1587f0.webp",980,1311]